These results were in contrast to clinical studies conducted by Mirioglu et al. [13] and Zhang et al. [14], who had reported that IgM and C3 co-deposition is an independent risk factor of poor renal outcome in patients with FSGS. The gene discussed is C3; the disease is focal segmental glomerulosclerosis.